Acumen Pharmaceuticals Statistics
Total Valuation
ABOS has a market cap or net worth of $191.05 million. The enterprise value is -$21.65 million.
| Market Cap | 191.05M |
| Enterprise Value | -21.65M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ABOS has 60.08 million shares outstanding. The number of shares has increased by 19.72% in one year.
| Shares Outstanding | 60.08M |
| Shares Change (YoY) | +19.72% |
| Shares Change (QoQ) | +6.98% |
| Owned by Insiders (%) | 9.13% |
| Owned by Institutions (%) | 72.66% |
| Float | 32.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.72 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.01, with a Debt / Equity ratio of 0.12.
| Current Ratio | 19.01 |
| Quick Ratio | n/a |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -89.14 |
Financial Efficiency
Return on equity (ROE) is -23.40% and return on invested capital (ROIC) is -20.51%.
| Return on Equity (ROE) | -23.40% |
| Return on Assets (ROA) | -21.80% |
| Return on Capital (ROIC) | -20.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.03M |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.87% in the last 52 weeks. The beta is 0.08, so ABOS's price volatility has been lower than the market average.
| Beta (1Y) | 0.08 |
| 52-Week Price Change | -15.87% |
| 50-Day Moving Average | 3.84 |
| 200-Day Moving Average | 4.23 |
| Relative Strength Index (RSI) | 33.58 |
| Average Volume (30 Days) | 343,856 |
Short Selling Information
The latest short interest is 1.24 million, so 2.06% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 2.06% |
| Short % of Float | 3.84% |
| Short Ratio (days to cover) | 2.78 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -61.14M |
| Pretax Income | -52.37M |
| Net Income | -52.37M |
| EBITDA | -51.61M |
| EBIT | -51.79M |
| Earnings Per Share (EPS) | -$1.08 |
Balance Sheet
The company has $243.76 million in cash and $31.05 million in debt, giving a net cash position of $212.71 million or $3.54 per share.
| Cash & Cash Equivalents | 243.76M |
| Total Debt | 31.05M |
| Net Cash | 212.71M |
| Net Cash Per Share | $3.54 |
| Equity / Book Value | 266.97M |
| Book Value Per Share | 4.44 |
| Working Capital | 233.64M |
Cash Flow
In the last 12 months, operating cash flow was -$43.06 million and capital expenditures -$18,000, giving a free cash flow of -$43.08 million.
| Operating Cash Flow | -43.06M |
| Capital Expenditures | -18,000 |
| Free Cash Flow | -43.08M |
| FCF Per Share | -$0.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.72% |
| Shareholder Yield | -19.72% |
| Earnings Yield | -27.41% |
| FCF Yield | -22.55% |
Analyst Forecast
The average price target for ABOS is $12.60, which is 296.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.60 |
| Price Target Difference | 296.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 5.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |